Simplex Trading’s ClearPoint Neuro CLPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$574K Buy
47,000
+34,900
+288% +$524K ﹤0.01% 3389
2026
Q2
$216K Sell
12,100
-1,500
-11% -$18.7K ﹤0.01% 4624
2026
Q1
$124K Sell
13,600
-12,400
-48% -$157K ﹤0.01% 4835
2025
Q4
$356K Sell
26,000
-38,900
-60% -$721K ﹤0.01% 3647
2025
Q3
$1.41M Buy
64,900
+60,200
+1,281% +$709K ﹤0.01% 2687
2025
Q2
$56K Buy
4,700
+3,900
+488% +$49.1K ﹤0.01% 5805
2025
Q1
$9K Sell
800
-18,100
-96% -$281K ﹤0.01% 7148
2024
Q4
$290K Buy
18,900
+13,900
+278% +$180K ﹤0.01% 4094
2024
Q3
$56K Sell
5,000
-3,100
-38% -$29.7K ﹤0.01% 5786
2024
Q2
$43K Sell
8,100
-12,000
-60% -$69.4K ﹤0.01% 6220
2024
Q1
$136K Buy
20,100
+19,500
+3,250% +$136K ﹤0.01% 5274
2023
Q4
$4K Sell
600
-5,900
-91% -$33.4K ﹤0.01% 7948
2023
Q3
$32K Sell
6,500
-800
-11% -$4.76K ﹤0.01% 6190
2023
Q2
$52K Buy
7,300
+1,900
+35% +$16.2K ﹤0.01% 5804
2023
Q1
$45K Buy
5,400
+4,200
+350% +$36.8K ﹤0.01% 6029
2022
Q4
$10K Sell
1,200
-18,100
-94% -$172K ﹤0.01% 7517
2022
Q3
$199K Buy
19,300
+2,300
+14% +$30.3K ﹤0.01% 4608
2022
Q2
$221K Buy
17,000
+13,300
+359% +$136K ﹤0.01% 4481
2022
Q1
$38K Sell
3,700
-15,500
-81% -$141K ﹤0.01% 7498
2021
Q4
$215K Buy
19,200
+10,000
+109% +$150K ﹤0.01% 5082
2021
Q3
$170K Sell
9,200
-500
-5% -$9.38K ﹤0.01% 5843
2021
Q2
$185K Buy
+9,700
New +$187K ﹤0.01% 5805

Other funds holding CLPT

Simplex Trading's CLPT Position: Q3 2026 in Review

Simplex Trading reduced its ClearPoint Neuro (CLPT) stake by 13% in Q3 2026, selling an estimated $37.5K and leaving 17,413 shares worth $213K. The position accounts for ﹤0.01% of the portfolio, ranked #4562.

Simplex Trading first reported a position in CLPT in Q1 2021 and has held it in 18 quarters since. The position peaked at $634K in Q3 2025. 74 funds tracked by Wall St. Rank hold CLPT as of Q3 2026.

  • Simplex Trading held 17,413 shares of ClearPoint Neuro worth $213K as of Q3 2026.
  • Simplex Trading sold 2,497 ClearPoint Neuro shares in Q3 2026, an estimated $37.5K.
  • ClearPoint Neuro made up ﹤0.01% of Simplex Trading's portfolio in Q3 2026, its #4562 holding.
  • Simplex Trading first reported a position in ClearPoint Neuro in Q1 2021 and has held it in 18 quarters since.
  • Simplex Trading's ClearPoint Neuro position peaked at $634K in Q3 2025.
  • 74 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q3 2026.

Based on Simplex Trading's 13F filing for Q3 2026, filed 4 Nov 2026.